Compare IPCA Labs with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs SOLARA ACTIVE PHARMA SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS SOLARA ACTIVE PHARMA SCIENCES IPCA LABS/
SOLARA ACTIVE PHARMA SCIENCES
 
P/E (TTM) x 30.4 25.7 118.3% View Chart
P/BV x 6.5 3.7 175.9% View Chart
Dividend Yield % 0.3 0.4 77.3%  

Financials

 IPCA LABS   SOLARA ACTIVE PHARMA SCIENCES
EQUITY SHARE DATA
    IPCA LABS
Mar-21
SOLARA ACTIVE PHARMA SCIENCES
Mar-21
IPCA LABS/
SOLARA ACTIVE PHARMA SCIENCES
5-Yr Chart
Click to enlarge
High Rs2,4561,625 151.1%   
Low Rs1,371415 330.5%   
Sales per share (Unadj.) Rs423.3450.0 94.1%  
Earnings per share (Unadj.) Rs90.661.6 147.0%  
Cash flow per share (Unadj.) Rs107.191.8 116.6%  
Dividends per share (Unadj.) Rs8.007.00 114.3%  
Avg Dividend yield %0.40.7 60.9%  
Book value per share (Unadj.) Rs370.6441.1 84.0%  
Shares outstanding (eoy) m126.8535.93 353.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.52.3 199.4%   
Avg P/E ratio x21.116.6 127.6%  
P/CF ratio (eoy) x17.911.1 160.9%  
Price / Book Value ratio x5.22.3 223.2%  
Dividend payout %8.811.4 77.7%   
Avg Mkt Cap Rs m242,72836,648 662.3%   
No. of employees `000NANA-   
Total wages/salary Rs m10,1362,294 441.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m53,69916,169 332.1%  
Other income Rs m1,292288 449.0%   
Total revenues Rs m54,99116,457 334.2%   
Gross profit Rs m14,8123,859 383.9%  
Depreciation Rs m2,0921,087 192.5%   
Interest Rs m123845 14.5%   
Profit before tax Rs m13,8902,215 627.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4012 160,093.3%   
Profit after tax Rs m11,4882,214 519.0%  
Gross profit margin %27.623.9 115.6%  
Effective tax rate %17.30.1 25,530.0%   
Net profit margin %21.413.7 156.3%  
BALANCE SHEET DATA
Current assets Rs m34,37010,576 325.0%   
Current liabilities Rs m11,3317,888 143.7%   
Net working cap to sales %42.916.6 258.0%  
Current ratio x3.01.3 226.2%  
Inventory Days Days4914 354.7%  
Debtors Days Days611 50.5%  
Net fixed assets Rs m26,29515,303 171.8%   
Share capital Rs m254359 70.6%   
"Free" reserves Rs m46,76315,488 301.9%   
Net worth Rs m47,01715,847 296.7%   
Long term debt Rs m3651,548 23.6%   
Total assets Rs m60,66425,880 234.4%  
Interest coverage x114.23.6 3,153.1%   
Debt to equity ratio x00.1 8.0%  
Sales to assets ratio x0.90.6 141.7%   
Return on assets %19.111.8 162.0%  
Return on equity %24.414.0 174.9%  
Return on capital %29.617.6 168.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27,1729,148 297.0%   
Fx outflow Rs m7,9496,688 118.8%   
Net fx Rs m19,2232,460 781.4%   
CASH FLOW
From Operations Rs m10,9011,555 701.2%  
From Investments Rs m-5,207-1,063 489.8%  
From Financial Activity Rs m-3,058925 -330.7%  
Net Cashflow Rs m2,6361,417 186.1%  

Share Holding

Indian Promoters % 46.1 41.9 110.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 39.9 23.4 170.8%  
FIIs % 15.9 16.7 95.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.9 58.1 92.7%  
Shareholders   56,982 54,173 105.2%  
Pledged promoter(s) holding % 0.0 8.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   ALEMBIC  WINDLAS BIOTECH  DR. REDDYS LAB  BETA DRUGS   VIVIMED LABS  



Today's Market

Sensex Opens Flat; Tata Motors & NTPC Top Gainers(09:30 am)

Asian stock markets opened lower today as investors tried to digest the crisis at Chinese property giant Evergrande. Markets in Korea and Hong Kong were shut.

Related Views on News

IPCA LABS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of IPCA LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of IPCA LABS. Also includes updates on the valuation of IPCA LABS.

IPCA LABS Announces Quarterly Results (1QFY22); Net Profit Down 30.8% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, IPCA LABS has posted a net profit of Rs 3 bn (down 30.8% YoY). Sales on the other hand came in at Rs 16 bn (up 2.0% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SOLARA ACTIVE PHARMA SCIENCES Announces Quarterly Results (1QFY22); Net Profit Up 18.5% (Quarterly Result Update)

Aug 5, 2021 | Updated on Aug 5, 2021

For the quarter ended June 2021, SOLARA ACTIVE PHARMA SCIENCES has posted a net profit of Rs 501 m (up 18.5% YoY). Sales on the other hand came in at Rs 4 bn (up 16.4% YoY). Read on for a complete analysis of SOLARA ACTIVE PHARMA SCIENCES's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Sep 22, 2021 11:16 AM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS